Praveen Kumar Marimuthu, Assistant Professor of Medical Oncology at Christian Medical College and Hospital, shared a post on X about a paper by Xinjia Ding et al. published in Scientific Reports:
“Real-world data in Muscle invasive bladder cancer shows that NACT plus immunotherapy (Tislelizumab/pembro) nearly doubled pCR vs chemo alone (48.3% vs 25.4%) and improved downstaging (76% vs 48%).”
Title: Real-world comparison of neoadjuvant chemoimmunotherapy and chemotherapy in muscle-invasive bladder cancer
Authors: Xinjia Ding, Chao Liu, Xiaohui Li, Zhigao Wang, Yanping Wu, Yi Song, Wei Yu, Shikai Wu
You can read the Full Article in Scientific Reports.
More posts featuring Praveen Kumar Marimuthu.
